Navigation Links
Marine microbes creating green waves in industry
Date:8/7/2009

New technology designed to analyse large numbers of novel marine microbes could lead to more efficient and greener ways to manufacture new drugs for conditions such as epilepsy, diabetes, flu and other viruses, as well as improving the manufacture of other products such as agrochemicals.

Researchers at Heriot-Watt University and Plymouth Marine Laboratory (PML) in collaboration with Edinburgh based company Ingenza Ltd are searching for new enzymes for use as manufacturing tools in the pharmaceutical and agrochemical industries. The research project, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Technology Strategy Board (TSB), uses biochemical techniques to identify potentially useful enzymes in microbes that are found in the sea.

This work brings important expertise from industry together with academic researchers. The value in this approach is to take specific knowledge and expertise in biochemistry and molecular biology, coupled with novel and diverse marine microbes, right through to high-yielding, scalable and economic manufacturing processes. These processes use enzyme catalysts from the marine microbes, which lead to greener and cleaner manufacturing methods.

Dr Robert Speight, from Ingenza Ltd, explained: "We are using biology in our chemical processes to come up with improved manufacturing routes. We are taking advantage of the natural diversity of marine organisms that has arisen through evolution in different environments and coupling that with high-tech screening systems. We are looking to find naturally occurring microbes that already have a built-in capacity to do the chemical reactions we want to perform in industry. There is every possibility of developing more efficient and sustainable manufacturing solutions - for pharmaceuticals and agrochemicals in particular - as a result of this search."

Microorganisms account for more than 95 per cent of ocean biomass but relatively little is really known about them and their potential applications. The research team's search is for industrially relevant enzymes which will reduce waste and increase productivity in the manufacture of drugs and agrochemicals. The enzymes they seek have the ability to convert compounds that would have previously been waste products in the manufacturing process, into the desired product, therefore increasing the efficiency of the process.

Professor Mark Keane, from Heriot-Watt University, said: "Our approach is to look for microbes which can promote the chemical reactions that we want to use in manufacturing. We then treat the microbes under conditions where they produce the key enzymes in higher yield, which we finally purify. The enzymes then undergo systematic testing to evaluate their activity, which enables us to pinpoint candidates that exhibit the best performance."

We are now identifying microbes with a type of enzyme called an amine oxidase. This could be key to cheaper, more efficient and sustainable process in the synthesis of valuable chemicals by both the pharmaceutical and agrochemical industries."

Commenting on the findings, BBSRC Chief Executive Professor Doug Kell, said: "Green and White biotechnologies are going to be an increasingly important part of the manufacturing landscape. Looking to biological systems that have been finely tuned by evolution to solve problems, rather than starting from scratch every time, might seem an obvious thing to do. It does however, in many cases, require the bringing together of particular niche expertise. The value of this collaboration is in the coincidence of knowledge and expertise from academia with the uniquely important business of synthesising a product on a large scale.

"What the outcomes of this project will offer us is the chance to have a significant impact on the sustainability of pharmaceutical and biochemicals production as we move from oil-based to photosynthesis-derived chemistry."


'/>"/>

Contact: Tracey Jewitt
press.office@bbsrc.ac.uk
44-179-341-4694
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. Marines land at UO, leave with plans to wear Oregon-made training suits
2. Gulf of Mexico dead zone to be studied by University of Texas at Austin marine scientists
3. US Army, US Navy, US Air Force, US Marines, US Department of Defense conference held at UH
4. Scripps scientists discover fluorescence in key marine creature
5. Pollution from marine vessels linked to heart and lung disease
6. Marine scientists warn human safety, prosperity depend on better ocean observing system
7. Present-day species of piranha result from a marine incursion into the Amazon Basin
8. Global climate change: The impact of El Niño on Galápagos marine iguanas
9. Global climate change: The impact of El Nio on Galpagos marine iguanas
10. Why diving marine mammals resist brain damage from low oxygen
11. Resilience concepts poised to aid management of coastal marine ecosystems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
Breaking Biology Technology: